Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vincent Strout
BIW-8962, an Anti GM2 Ganglioside Monoclonal Antibody, in Previously Treated Advanced/Recurrent Lung Cancer: A Phase I/Ii Study
Journal of Cancer Biology and Therapeutics
Related publications
Phase I/Ii Study of Gefitinib (Iressa®) and Vorinostat (IVORI) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Phase 1 Experience With an Anti-Glycotope Monoclonal Antibody, RAV12, in Recurrent Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
A Phase 1 Study of Anti-TGFβ Receptor Type-Ii Monoclonal Antibody LY3022859 in Patients With Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I First-In-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Subacute Sensorimotor Neuropathy Accompanied by Anti-Ganglioside GM1 Antibody in a Patient With Lung Cancer
Internal Medicine
Internal Medicine
Medicine
Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: A Prospective Phase II Study
British Journal of Cancer
Cancer Research
Oncology